- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03632382
Non-invasive Device for the Screening and Diagnosis of Sleep Apnea Syndrome (Episas)
February 9, 2021 updated by: University Hospital, Grenoble
This prospective study aims to establish and evaluate a predictive model to diagnose OSA with maxillofacial characteristics 3D acquisition.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Polysomnography is the gold-standard for obstructive sleep apnea (OSA) diagnosis.
However, OSA is still undiagnosed.
Maxillofacial profile can influence OSA severity.
Morphological characteristics can be identified but are not enough measurable and analysable by physicians.
3D acquisition of maxillofacial characteristics with a user-friendly tool, quick and low-priced could be used to obtain a predictive model as an OSA risk indicator.
Thus, the aim of this study is to establish and evaluate a predictive model to diagnose OSA with maxillofacial characteristics 3D acquisition.
Study Type
Interventional
Enrollment (Actual)
280
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Grenoble, France
- Grenoble Alpes University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- BMI < 35 kg/m²
- caucasian men
- patients from the sleep laboratory (CHU Grenoble Alpes) admitted for a polysomnography
- Patient who has given free and informed consent in writing
Exclusion Criteria:
- history of maxillofacial surgery
- dental malocclusion
- patient involved in another clinical research study
- patient not affiliated with social security
- patient deprived of liberty or hospitalized without consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: OSA diagnosis with 3D acquisition
|
A 3D acquisition of maxillofacial characteristics will be performed for each patient in order to validate a predictive model comparable to data obtained by polysomnography
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Establish and evaluate a predictive model for OSA diagnosis by 3D acquisition of characteristics maxillofacial
Time Frame: 1 measure at inclusion
|
apnea hypopnea index will be measured by polysomnography for each patient and compared to a predictive model establish from body mass index and 3D acquisition (cricomental distance...)
|
1 measure at inclusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sensitivity study from different stages of OSA severity
Time Frame: 1 measure at inclusion
|
OSA severity stages will be apnea hypopnea index <5, <10, <15
|
1 measure at inclusion
|
Compare diagnosis performances of predictive model and Berlin or NoSAS questionnaires
Time Frame: 1 measure at inclusion
|
Correlation between the Berlin or NoSAS score and the predictive model results
|
1 measure at inclusion
|
Evaluate performances of the combination (Berlin questionnaire + predictive model) to estimate the OSA risk
Time Frame: 1 measure at inclusion
|
Calculate the sensitivity, specificity, predictive positive value and predictive negative value of the combination
|
1 measure at inclusion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jean-Louis PEPIN, Chu Grenoble Alpes
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 27, 2018
Primary Completion (Actual)
July 27, 2018
Study Completion (Actual)
September 8, 2020
Study Registration Dates
First Submitted
August 13, 2018
First Submitted That Met QC Criteria
August 13, 2018
First Posted (Actual)
August 15, 2018
Study Record Updates
Last Update Posted (Actual)
February 10, 2021
Last Update Submitted That Met QC Criteria
February 9, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 38RC17.359
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obstructive Sleep Apnea
-
LivaNovaActive, not recruitingApnea | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | Apnea+Hypopnea | Apnea, Obstructive Sleep | Hypopnea, SleepUnited States
-
Mauro ManconiCompletedObstructive Sleep Apnea Syndrome | Sleep Apnea, Obstructive | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | OSAHSwitzerland
-
University of California, Los AngelesRecruiting
-
Brigham and Women's HospitalCompletedObstructive Sleep Apnea (OSA)United States
-
ApnimedCompletedOSA - Obstructive Sleep ApneaUnited States
-
State Budgetary Healthcare Institution, National...RecruitingObstructive Sleep Apnea | Obstructive Sleep Apnea-hypopnea | Obstructive Sleep Apnea-hypopnea SyndromeRussian Federation
-
The Hospital for Sick ChildrenCompleted
-
Cryosa, Inc.Active, not recruitingObstructive Sleep Apnea of AdultPanama, Paraguay
-
State Key Laboratory of Respiratory DiseaseCompletedObstructive Sleep Apnea of AdultChina
-
Somnics, Inc.UnknownObstructive Sleep Apnea of AdultTaiwan
Clinical Trials on 3D acquisition of maxillofacial characteristics
-
University of MichiganRecruitingMaxillofacial Abnormalities | Craniofacial Abnormalities | Prosthetic TreatmentUnited States
-
Xinqiao Hospital of ChongqingCompletedNasopharyngeal CarcinomaChina
-
Hospices Civils de LyonCompleted
-
AZ NikolaasCompleted
-
Tishreen UniversityCompletedMucormycosis | Maxillofacial Trauma | Face CancerSyrian Arab Republic
-
Poitiers University HospitalActive, not recruiting
-
Methodist Health SystemCompletedNon-Alcoholic Fatty Liver Disease | Non Alcoholic SteatohepatitisUnited States
-
Institut Paoli-CalmettesUnknown